We live and breathe our pledge to push the boundaries of medical science every day, in every way possible. We understand the impact of the life-changing medical conditions we treat.
At Merck Serono, the biopharmaceutical division of Merck, we discover, develop, manufacture and market innovative small molecules and biopharmaceuticals in our focus therapeutic areas.
Merck Serono is the biopharmaceutical division of Merck. With headquarters in Darmstadt, Germany and over 16,000 people worldwide, we’re active on all continents and offer leading brands in 150 countries. In the United States and Canada, EMD Serono operates through separately incorporated affiliates.
Currently, our R&D pipeline includes around 70 projects prior to Phase I and over 100 clinical studies from Phase I onwards. As well as our own integrated research and development facilities, we have a network of alliances with other biotech companies and academic groups. This promotes a constant flow of innovation into the organization by enriching our disease knowledge and technological capabilities.